Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01693796
Other study ID # 2010-A01118-31
Secondary ID 2010-09
Status Completed
Phase N/A
First received
Last updated
Start date March 2011
Est. completion date April 2015

Study information

Verified date August 2015
Source Assistance Publique Hopitaux De Marseille
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the average risk for thyroid irradiation for any type of paediatric cardiac catheterization, based on the cummulative at-risk dose of 100 mSv, adjusted to the measured thyroid volume and to the patient's age.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date April 2015
Est. primary completion date April 2015
Accepts healthy volunteers No
Gender All
Age group N/A to 18 Years
Eligibility Inclusion Criteria: - Inclusion of any patient (< 18 year-old) with congenital heart disease undergoing one or more cardiac catheterization Exclusion Criteria: - Exclusion of patients with any type of thyroid dissease

Study Design


Intervention

Other:
blood and urine samples ; Echography


Locations

Country Name City State
France Assistance Publique Hopitaux de Marseille Marseille

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary exposure to radiation measure To determine the average risk for thyroid irradiation for any type of paediatric cardiac catheterization, based on the cummulative at-risk dose of 100 mSv, adjusted to the measured thyroid volume and to the patient's age. 2 YEARS
Secondary exposure to radiation measure Fit the dose of average irradiation of the thyroid during the catheterizations to the thyroïdien volume 2 YEARS